Myconostica Announces Publication of Trial Results with MycAssay TM Pneumocystis Kit
Manchester, United Kingdom, April 4, 2011 / b3c newswire / - Myconostica, specialising in rapid molecular diagnostic tests for life-threatening fungal infections, announces the publication ( Hauser et al, J. Clin. Microbiol.) of a multicentre prospective trial of its CE marked kit, MycAssay™ Pneumocystis for the detection of Pneumocystis jirovecii. The trial results compare well with clinical diagnosis using non-molecular methods and demonstrate the high sensitivity and specificity of the PCR diagnostic assay.